| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| May 14, 2025 | May 19, 2025 | Levy Richard S Dir | Buy | Protara Therapeutics, Inc. | TARA | $3.19 | $63,800 | +28.17% |
| May 14, 2025 | May 16, 2025 | Levy Richard S Dir | Buy | Protara Therapeutics, Inc. | TARA | $3.19 | $63,800 | +28.17% |
| Nov 07, 2024 | Nov 08, 2024 | Levy Richard S Dir | Sell | Madrigal Pharmaceuticals, Inc. | MDGL | $350 | $2M | -31.23% |
| Nov 01, 2024 | Nov 06, 2024 | Levy Richard S Dir | Sell | Madrigal Pharmaceuticals, Inc. | MDGL | $300.94 | $2M | -31.23% |
| Apr 01, 2024 | Apr 04, 2024 | Levy Richard S Dir | Sell | Madrigal Pharmaceuticals, Inc. | MDGL | $257.49 | $3M | -51.65% |
| Jan 17, 2023 | Jan 20, 2023 | Levy Richard S Dir | Sell | Madrigal Pharmaceuticals, Inc. | MDGL | $293.15 | $7M | -71.19% |
| Mar 20, 2020 | Mar 24, 2020 | Levy Richard S Dir | Buy | Kodiak Sciences Inc. | KOD | $44.33 | $44,330 | +50.00% |
| Nov 30, 2017 | Dec 01, 2017 | Levy Richard EVP Controller | Sell | Wells Fargo & Company/mn | WFC | $56.47 | $5M | -58.60% |
| Aug 23, 2017 | Aug 24, 2017 | Levy Richard S Dir | Buy | Madrigal Pharmaceuticals, Inc. | MDGL | $16.12 | $32,236 | +18.02% |
| Aug 22, 2017 | Aug 23, 2017 | Levy Richard S Dir | Buy | Madrigal Pharmaceuticals, Inc. | MDGL | $16.12 | $57,209 | +33.33% |
| Aug 21, 2017 | Aug 22, 2017 | Levy Richard S Dir | Buy | Madrigal Pharmaceuticals, Inc. | MDGL | $15.88 | $56,358 | +50.00% |
| Jan 06, 2016 | Jan 08, 2016 | Levy Richard S EVP Chief Drug Dev Officer | Sell | Incyte Corp | INCY | $101.86 | $401,023 | -18.87% |
| Dec 07, 2015 | Dec 09, 2015 | Levy Richard S EVP Chief Drug Dev Officer | Sell | Incyte Corp | INCY | $106.18 | $418,031 | -18.87% |
| Nov 06, 2015 | Nov 11, 2015 | Levy Richard S EVP Chief Drug Dev Officer | Sell | Incyte Corp | INCY | $116.51 | $458,583 | -18.87% |
| Oct 06, 2015 | Oct 08, 2015 | Levy Richard S EVP Chief Drug Dev Officer | Sell | Incyte Corp | INCY | $122.29 | $481,456 | -18.87% |
| Sep 11, 2015 | Sep 15, 2015 | Levy Richard S EVP Chief Drug Dev Officer | Sell | Incyte Corp | INCY | $130 | $559,130 | -20.26% |
| Sep 08, 2015 | Sep 10, 2015 | Levy Richard S EVP Chief Drug Dev Officer | Sell | Incyte Corp | INCY | $118.9 | $468,109 | -15.65% |
| Aug 06, 2015 | Aug 10, 2015 | Levy Richard S EVP Chief Drug Dev Officer | Sell | Incyte Corp | INCY | $111.95 | $440,635 | -15.64% |
| Jul 15, 2015 | Jul 16, 2015 | Levy Richard S EVP Chief Drug Dev Officer | Sell | Incyte Corp | INCY | $120 | $8M | -76.79% |
| Jul 06, 2015 | Jul 08, 2015 | Levy Richard S EVP Chief Drug Dev Officer | Sell | Incyte Corp | INCY | $107 | $421,259 | -15.65% |
| Jun 19, 2015 | Jun 23, 2015 | Levy Richard S EVP Chief Drug Dev Officer | Sell | Incyte Corp | INCY | $108.13 | $2M | -48.51% |
| Jun 08, 2015 | Jun 10, 2015 | Levy Richard S EVP Chief Drug Dev Officer | Sell | Incyte Corp | INCY | $107.58 | $423,542 | -15.65% |
| May 06, 2015 | May 08, 2015 | Levy Richard S EVP Chief Drug Dev Officer | Sell | Incyte Corp | INCY | $99.43 | $736,975 | -25.88% |
| Apr 15, 2015 | Apr 17, 2015 | Levy Richard EVP Controller | Sell | Wells Fargo & Company/mn | WFC | $54.48 | $5M | -50.24% |
| Apr 06, 2015 | Apr 08, 2015 | Levy Richard S EVP Chief Drug Dev Officer | Sell | Incyte Corp | INCY | $88.77 | $2M | -54.08% |
| Mar 06, 2015 | Mar 10, 2015 | Levy Richard S EVP Chief Drug Dev Officer | Sell | Incyte Corp | INCY | $89.91 | $2M | -54.08% |
| Feb 17, 2015 | Feb 18, 2015 | Levy Richard S EVP Chief Drug Dev Medical O | Sell | Incyte Corp | INCY | $76.9 | $922,800 | -39.73% |
| Feb 06, 2015 | Feb 10, 2015 | Levy Richard S EVP Chief Drug Dev Medical O | Sell | Incyte Corp | INCY | $75.11 | $2M | -57.86% |
| Jan 16, 2015 | Jan 20, 2015 | Levy Richard S EVP Chief Drug Dev Medical O | Sell | Incyte Corp | INCY | $73.07 | $876,840 | -39.73% |
| Jan 06, 2015 | Jan 08, 2015 | Levy Richard S EVP Chief Drug Dev Medical O | Sell | Incyte Corp | INCY | $71.84 | $2M | -57.86% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.